Cargando…
A novel inhibitor of hypoxia-inducible factor-1α P3155 also modulates PI3K pathway and inhibits growth of prostate cancer cells
BACKGROUND: Hypoxia-inducible factor-1 (HIF-1) is a master regulator of the transcriptional response to hypoxia. It is essential for angiogenesis and is associated with tumor progression and overexpression of HIF-1α has been demonstrated in many common human cancers. Therefore, HIF-1α is one of the...
Autores principales: | Manohar, Sonal M, Padgaonkar, Amol A, Jalota-Badhwar, Archana, Sonawane, Vinay, Rathos, Maggie J, Kumar, Sanjay, Joshi, Kalpana S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224262/ https://www.ncbi.nlm.nih.gov/pubmed/21819554 http://dx.doi.org/10.1186/1471-2407-11-338 |
Ejemplares similares
-
Potentiation of in vitro and in vivo antitumor efficacy of doxorubicin by cyclin-dependent kinase inhibitor P276-00 in human non-small cell lung cancer cells
por: Rathos, Maggie J, et al.
Publicado: (2013) -
Molecular evidence for increased antitumor activity of gemcitabine in combination with a cyclin-dependent kinase inhibitor, P276-00 in pancreatic cancers
por: Rathos, Maggie J, et al.
Publicado: (2012) -
Logarithmic or linear automatic RF voltage control: Module PS/RF-HC3155
por: Grier, D, et al.
Publicado: (1994) -
Molecular mechanisms of anti-tumor properties of P276-00 in head and neck squamous cell carcinoma
por: Mishra, Prabha B, et al.
Publicado: (2013) -
Ketorolac modulates Rac-1/HIF-1α/DDX3/β-catenin signalling via a tumor suppressor prostate apoptosis response-4 (Par-4) in renal cell carcinoma
por: Sonawane, Vinay, et al.
Publicado: (2023)